Omnichannelcquisition Corp. Class A (OCA) Peer Comparison
$10.00
$-0.01
(-0.05%)
As on 31-May-2022 12:16EDT
Market cap
$258 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
41.3
P/B Ratio
1.4
Div. Yield
0 %
Edit
| Omnichannelcquisition Corp. Class A (OCA) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
258 | 5,723 | 3,425 | 812 | 427 |
Revenue ($ Mln) |
-- | 440 | 2,883 | -- | 58 |
Net Profit ($ Mln) |
15.16 | -1,435.01 | -118.30 | -134.20 | -50.70 |
Net Margin (%) |
-- | -325.91 | -4.10 | -- | -88.09 |
RoE (%) |
-- | -- | -- | -40.17 | -54.90 |
Price to Earnings |
41.30 | -- | -- | -- | -- |
Price-To-Book |
1.39 | -- | 1.35 | -- | 2.89 |
Income Statement ($ Mln)
| Omnichannelcquisition Corp. Class A (OCA) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 544.48 | 2,716.30 | 32.22 | 27.44 |
|
Cost of Revenue
|
0.00 | 305.62 | 1,922.10 | 0.30 | 22.48 |
|
Gross Profit
|
-- | 238.86 | 794.20 | 31.92 | 4.96 |
|
Operating Expenses
|
5.89 | 5.21 | 682.30 | 162.14 | 62.72 |
|
Operating Profit (EBIT)
|
-4.00 | -5.21 | 111.90 | -129.92 | -57.76 |
|
Other Income
|
0.00 | -- | 0.00 | 0.86 | 0.76 |
|
Profit before Tax
|
15.16 | -32.50 | 11.20 | -131.76 | -107.09 |
|
Provision for Tax
|
0.00 | 15.76 | 17.30 | -- | 0.07 |
|
Profit after Tax (Net Income)
|
15.16 | -32.50 | 11.10 | -131.76 | -107.09 |
|
Minority Interest
|
0.00 | -- | -- | -- | -- |
|
Consolidated Profit
|
6.25 | 47.31 | -0.34 | -131.76 | 10.20 |
Liabilities ($ Mln)
| Omnichannelcquisition Corp. Class A (OCA) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-13.99 | 280.79 | -261.30 | 286.12 | 110.42 |
|
Minority Interest
|
0.00 | -- | -- | -- | -- |
|
Non-Current Liabilities
|
10.98 | 61.37 | 2,376.90 | 76.52 | 145.64 |
|
Current Liabilities
|
3.34 | 4.21 | 1,887.10 | 63.02 | 46.66 |
|
Total Liabilities
|
206.99 | 346.37 | 4,325.70 | 425.65 | 302.72 |
Assets ($ Mln)
| Omnichannelcquisition Corp. Class A (OCA) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
206.54 | 345.03 | 3,313.70 | 156.48 | 34.64 |
|
Current Assets
|
0.29 | 1.33 | 1,012.00 | 269.18 | 268.07 |
|
Total Assets
|
0.49 | 346.37 | 4,325.70 | 425.65 | 302.72 |
|
Total Debt*
|
0.00 | 818.81 | 2,764.50 | 23.64 | 19.51 |
|
Net Current Assets
|
-3.05 | 436.27 | 1.33 | 206.16 | 0.84 |
Cashflow ($ Mln)
| Omnichannelcquisition Corp. Class A (OCA) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.36 | -1.87 | -435.00 | -75.62 | -56.40 |
|
Cash Flow from Investing Activities
|
0.02 | -423.84 | -180.70 | 92.22 | -33.59 |
|
Cash from Financing Activities
|
0.65 | 347.84 | 525.50 | 1.08 | 282.89 |
|
Net Cash Inflow / Outflow
|
-- | -- | 1.42 | 17.68 | 1.13 |
Ratios
Profitability Ratios
| Omnichannelcquisition Corp. Class A (OCA) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
7.69 | -5.10 | 0.48 | -34.71 | -694.65 |
|
ROE (%)
|
7.69 | -15.68 | -4.46 | -39.23 | -8,256.82 |
|
ROA (%)
|
7.23 | -11.36 | 0.28 | -27.90 | -63.86 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-- | -5.97 | 0.41 | -398.26 | -379.73 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Omnichannelcquisition Corp. Class A (OCA) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 8.03 | 0.42 | -0.50 | 0.45 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
2,942.55 | -166.25 | 156.63 | -138.01 | -391.09 |
|
EPS Growth (%)
|
-- | -1.66 | 1.97 | -1.24 | -1.00 |
|
Book Value Growth (%)
|
-379.71 | -- | -- | -- | -- |
Valuation Ratios
| Omnichannelcquisition Corp. Class A (OCA) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
7.18 | -106.90 | 14.22 | -19.34 | -3.56 |
|
Price / Book Value
|
-2.45 | 12.37 | -0.60 | 8.91 | 3.46 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | 70.38 | 1.59 | -17.58 | -1.74 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Omnichannelcquisition Corp. Class A (OCA) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-0.06 | 2.92 | -10.58 | 0.08 | 0.18 |
|
Short term debt to equity ratio
|
0.00 | 0.37 | -3.38 | 0.07 | 0.07 |
|
Current Ratio
|
0.09 | 0.32 | 0.54 | 4.27 | 5.75 |
|
Quick Ratio
|
0.09 | -- | 0.54 | 4.26 | 5.26 |
|
Interest Coverage
|
-- | 0.62 | 1.16 | -49.89 | -38.08 |
Operating Efficiency Ratios
| Omnichannelcquisition Corp. Class A (OCA) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 0.31 | 25.56 | 1.28 | 47.57 |
|
Asset Turnover
|
0.00 | 1.90 | 0.68 | 0.07 | 0.16 |
|
Receivable days
|
-- | 0.94 | 77.39 | 3.29 | 115.26 |
|
Inventory Days
|
-- | -- | 0.00 | 1,029.23 | 241.98 |
|
Payable days
|
-- | 1.98 | 33.34 | 11,865.18 | 90.24 |
|
Cash Conversion Cycle
|
-- | -- | 44.05 | -10,832.66 | 267.00 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
